Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Lipids and cardiovascular/metabolic health

13C mixed triglyceride breath testing using infrared spectrometry: comparison of two devices in early infancy

Abstract

Background/Objectives:

The 13C mixed triglyceride (MTG) breath test has been proposed for the non-invasive assessment of fat digestion and absorption. To evaluate whether reference values for the adequacy of fat absorption, set in the non-dispersive infrared spectrometry (NDIRS) system software proposed for healthy children and adults using the 13C MTG breath test, are also applicable to infants of <5 months of age.

Subjects/Methods:

13C MTG breath testing with the NDIRS technique was performed in 54 healthy infants <5 months of age (38 breast-fed, 16 formula-fed) and six infants diagnosed with cystic fibrosis (CF) using two NDIRS devices, IRIS and FANci2.

Results:

The IRIS results were slightly higher compared with those assessed by the FANci2 device. The minimum cutoff value for pancreatic sufficiency (PS) is set as a cumulative percentage dose of 13C recovered (cPDR) after 5 h of 13.0%. Pancreatic function status of six CF infants, three with PS and three with pancreatic insufficiency (PI), according to the 72 h-faecal fat balance test could be correctly determined with the 13C MTG breath test using two NDIRS techniques. However, if these reference values had been used to determine pancreatic function status in healthy infants, 26 out of 54 infants would have been misclassified as pancreatic insufficient.

Conclusions:

Although the 13C MTG breath test with the MS technique has the potential to be a suitable assessment of fat absorption in infants, the technique of NDIRS appears too insensitive in an infant population group.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Braden B, Haisch M, Duan LP, Lembcke B, Caspary WF, Hering P . Clinically feasible stable isotope technique at a reasonable price: analysis of 13CO2/12CO2-abundance on breath samples with a new isotope selective non dispersive infrared spectrometer. Z Gastroenterol 1994; 32: 675–678.

    CAS  PubMed  Google Scholar 

  2. Kalivianakis M, Verkade HJ, Stellaard F, van der Were M, Elzinga H, Vonk RJ . The 13C-mixed triglyceride breath test in healthy adults: determinants of the 13CO2 response. Eur J Clin Invest 1997; 27: 434–442.

    Article  CAS  Google Scholar 

  3. Vantrappen GR, Rutgeerts PJ, Ghoos YF, Hiele MI . Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterol 1989; 96: 1126–1134.

    Article  CAS  Google Scholar 

  4. Amarri S, Harding M, Coward WA, Evans TJ, Weaver LT . 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 1997; 76: 349–351.

    Article  CAS  Google Scholar 

  5. Herzog DC, Delvin EE, Albert C, Marcotte JE, Pelletier VA, Seidman EG . 13C-labeled mixed triglyceride breath test (13C MTG-BT) in healthy children and children with cystic fibrosis (CF) under pancreatic enzyme replacement therapy (PERT): A pilot study. Clin Biochem 2008; 41: 1489–1492.

    Article  CAS  Google Scholar 

  6. Van Dijk-van Aalst K, Van Den Driessche M, Van Der Schoor S, Schiffelers S, van't Westeinde T, Ghoos Y et al. 13C mixed triglyceride breath test: a non invasive method to assess lipase activity in children. J Pediatr Gastroenterol Nutr 2001; 32: 579–585.

    Article  CAS  Google Scholar 

  7. Manson WG, Coward WA, Harding M, Weaver L . Development of fat digestion in infancy. Arch Dis Child Fetal Neonatal Ed 1990; 80: F183–F187.

    Article  Google Scholar 

  8. Boeck WG, Adler G, Gress TM . Pancreatic function tests: when to choose, what to use. Curr Gastroenterol Rep 2001; 3: 95–100.

    Article  CAS  Google Scholar 

  9. Waters DL, Dorney SFA, Gaskin KJ, Gruca MA, O'Halloran M, Wilcken B . Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med 1990; 322: 303–308.

    Article  CAS  Google Scholar 

  10. Haisch M, Hering P, Fabinski W, Zochbauer M . Isotopenselektive Konzentrations-messungen an Atemgasen mit einem NDIR-Spektrometer. Tech Messen 1996; 63: 322–328.

    CAS  Google Scholar 

  11. Haisch M, Hering P, Fuss W, Fabinski W . A sensitive isotope selective nondispersive infrared spectrometer for 13CO2 and 12CO2 concentration measurements in breath samples. Isotopenprax Environ Health Stud 1994; 30: 247–251.

    Article  CAS  Google Scholar 

  12. Jonderko K, Dus Z, Szymszal M, Kasicka-Jonderko A, Blonska-Fajfrowska B . Normative values for the 13C-mixed triglyceride breath test in two age groups. Med Sci Monit 2009; 15: CR255–CR259.

    CAS  PubMed  Google Scholar 

  13. Swart GR, Baartman EA, Wattimena JLD, Rietveld T, Overbeek SE, van den Berg JW . Evaluation studies of the 13C-mixed triglyceride breath test in healthy controls and adult cystic fibrosis patients with exocrine pancreatic insufficiency. Digestion 1997; 58: 415–420.

    Article  CAS  Google Scholar 

  14. Weaver LT, Amarri S, Swart GR . 13C mixed triglyceride breath test. Gut 1998; 43: S13–S19.

    Article  Google Scholar 

  15. Watkins JB, Klein PD, Schoeller DA, Kirschner BS, Park R, Perman JA . Diagnosis and differentiation of fat malabsorption in children using 13C-labelled lipids: trioctanoin, triolein, and palmitic acid breath tests. Gastroenterol 1982; 82: 911–917.

    CAS  Google Scholar 

  16. Keller J, Brückel S, Jahr C, Layer P . A modified 13C-mixed triglyceride breath test detects moderate pancreatic exocrine insufficiency. Pancreas 2011; 40: 1201–1205.

    Article  CAS  Google Scholar 

  17. Adamek RJ, Bodeker C, Szymanski C, Hagemann D, Pfaffenbach B . 13C-mixed triglyceride CO2 exhalation test. Investigation with an isotope selective, non dispersive infrared spectrophotometer of indirect function of the exocrine pancreas. Dtsch Med Wochenschr 1999; 124: 103–108.

    Article  CAS  Google Scholar 

  18. Boedeker C, Goetze O, Pfaffenbach B, Luypaerts A, Geypens B, Adamek RJ . 13C Mixed triglyceride breath test: isotope selective non-dispersive infrared spectrometry in comparison with isotope ratio mass spectrometry in volunteers and patients with chronic pancreatitis. Scand J Gastroenterol 1999; 11: 1153–1156.

    Article  Google Scholar 

Download references

Acknowledgements

This research project was supported by grants from the James Fairfax Institute of Paediatric Nutrition and the Johno Johnston Scholarship (DSK), at The Children’s Hospital at Westmead, Sydney, Australia. We also like to express our sincere gratitude to all participating mothers and their infants.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D S Kent.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kent, D., Remer, T., Blumenthal, C. et al. 13C mixed triglyceride breath testing using infrared spectrometry: comparison of two devices in early infancy. Eur J Clin Nutr 70, 959–962 (2016). https://doi.org/10.1038/ejcn.2015.228

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2015.228

Search

Quick links